Document is current

Article History

Received: 28 May 2024

Accepted: 11 October 2024

First Online: 25 October 2024

Declarations

:

: (1) Title of the approved project: The study, title “Intrauterine Adhesions Repair with Menstrual Blood-derived Mesenchymal Stem Cells via CXCL13-CXCR5 Signal Axis and its Mechanism” has been approved by the institute review board. (2) Name of the institutional approval committee or unit: Animal Management and Ethics Committee of West China Second Hospital of Sichuan University. (3) Approval number: (2021064). (4) Date of approval: March 4, 2021. (5) Voluntary healthy women who provided menstrual blood have written informed consent forms for participation in this study, The use of menstrual blood from healthy women in this study was also approved by the Ethics Committee of West China Second Hospital of Sichuan University, Approval number: (2020103), and date of approval, March 25, 2020. All investigations were conducted according to the principles expressed in the Declaration of Helsinki.

: Not applicable.

: The authors declare that they have no competing interests.

: All authors have no conflicts of interest to declare.